SCHEMBL14901084

SCHEMBL14901084

OC(c1cccc(-n2c3ccccc3c3ccccc32)c1)(c1cccc(-n2c3ccccc3c3ccccc32)c1)c1ccc2ccccc2c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KMT2A Q03164 4/20 0.38
▸ PLA2G10 O15496 2/20 0.36
▸ TSHR P16473 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15505858 0.80 HSD17B10 (0.60) CYP1A2CYP2D6CYP2C9CYP2C19HPGD
SCHEMBL14901082 0.80 L3MBTL1 (0.44) HPGDHSD17B10KDM4EATML3MBTL1
SCHEMBL14901088 0.76 KDM4E (0.40) KDM4EATML3MBTL1KMT2APLA2G10
SCHEMBL14901087 0.76 KDM4E (0.40) KDM4EATML3MBTL1KMT2APLA2G10
SCHEMBL14901090 0.75 KDM4E (0.39) CYP1A2CYP2C19HSD17B10KDM4EATM
SCHEMBL14901085 0.75 KDM4E (0.39) CYP2C19KDM4EATML3MBTL1KMT2A
SCHEMBL13233167 0.72 KDM4E (0.42) HPGDKDM4EATML3MBTL1KMT2A
SCHEMBL15997131 0.70 KDM4E (0.43) HSD17B10KDM4EATML3MBTL1KMT2A
SCHEMBL17718058 0.70 KDM4E (0.44) CYP1A2KDM4EATML3MBTL1KMT2A
SCHEMBL24127584 0.70 L3MBTL1 (0.59) KDM4EATML3MBTL1KMT2APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051266-B2 Carbazole derivatives and organic light emitting diodes comprising the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-06-09 — — US disclosed
US-9051266-B2 Carbazole derivatives and organic light emitting diodes comprising the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-06-09 — — US disclosed
US-20130105767-A1 CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2013-05-02 — — US disclosed
US-20130105767-A1 CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2013-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130105767-A1 CARBAZOLE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES COMPRISING THE SAME DRD1, DRD3, DOT1L CYP1A2 53/4885CYP2D6 603/4885CYP2C9 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback